85 related articles for article (PubMed ID: 22405693)
1. [Whole brain radiotherapy for brain metastases: the technique of irradiation influences the dose to parotid glands].
Loos G; Paulon R; Verrelle P; Lapeyre M
Cancer Radiother; 2012 Apr; 16(2):136-9. PubMed ID: 22405693
[TBL] [Abstract][Full Text] [Related]
2. Parotid gland as a risk organ in whole brain radiotherapy.
Noh OK; Chun M; Nam SS; Jang H; Jo S; Oh YT; Lim JC
Radiother Oncol; 2011 Feb; 98(2):223-6. PubMed ID: 21300416
[TBL] [Abstract][Full Text] [Related]
3. Parotid glands in whole-brain radiotherapy: 2D versus 3D technique for no sparing or sparing.
Trignani M; Genovesi D; Vinciguerra A; Di Pilla A; Augurio A; Di Tommaso M; Cèfaro GA; Di Nicola M
Radiol Med; 2015 Mar; 120(3):324-8. PubMed ID: 25033946
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
5. [Presentation of a 3D conformal radiotherapy technique for head-and-neck tumors resulting in substantial protection of the parotid glands].
Kuhnt T; Janich M; Götz U; Gerlach R; Chiricuta IC; Hänsgen G
Strahlenther Onkol; 2006 Jun; 182(6):325-30. PubMed ID: 16703287
[TBL] [Abstract][Full Text] [Related]
6. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between the parotid glands function and the dose-volume effect in nasopharyngeal carcinoma patients with intensity-modulated radiation therapy].
Sun XN; Chen AZ; Xie CY; Jin XC; Wu SX; Zhang P; Li HB
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2289-92. PubMed ID: 17064579
[TBL] [Abstract][Full Text] [Related]
8. Whole-brain Irradiation Field Design: A Comparison of Parotid Dose.
Wu CC; Wuu YR; Jani A; Saraf A; Tai CH; Lapa ME; Andrew JIS; Tiwari A; Saadatmand HJ; Isaacson SR; Cheng SK; Wang TJC
Med Dosim; 2017 Summer; 42(2):145-149. PubMed ID: 28479012
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
10. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
11. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
12. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
[TBL] [Abstract][Full Text] [Related]
13. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy.
Hsu F; Carolan H; Nichol A; Cao F; Nuraney N; Lee R; Gete E; Wong F; Schmuland M; Heran M; Otto K
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1480-5. PubMed ID: 19625140
[TBL] [Abstract][Full Text] [Related]
14. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
15. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
16. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
17. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
18. Improvement in dose homogeneity with electronic tissue compensation over IMRT and conventional RT in whole brain radiotherapy.
Goyal S; Yue NJ; Millevoi R; Kagan E; Haffty B; Narra V
Radiother Oncol; 2008 Aug; 88(2):196-201. PubMed ID: 18362037
[TBL] [Abstract][Full Text] [Related]
19. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the parotid function in nasopharyngeal carcinoma treated with parotid-sparing radiotherapy.
Liu WS; Lee SP; Lee JK; Su MC; Chen GD; Lee HS; Lee H
Jpn J Clin Oncol; 2006 Oct; 36(10):626-31. PubMed ID: 17008345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
